Primary effusion lymphoma - Open Access .click

Results 181 to 190 of about 4,756,303 (211)

Some of the next articles are maybe not open access.

Current Opinion in Pulmonary Medicine, 2017
To summarize the current epidemiology, management, and outcomes of primary effusion lymphoma (PEL) and highlight possible future research efforts.Cyclophosphamide, doxorubicin, vincristine, prednisone-based chemotherapy regimens alone or in combination with immunomodulatory agents (e.g., lenalidomide), or proteasome inhibitors (e.g., bortezomib), or ...
Nivedita, Arora, Arjun, Gupta, Navid, Sadeghi +2 more
openaire +2 more sources

Daratumumab in Primary Effusion Lymphoma

New England Journal of Medicine, 2018
Daratumumab in Primary Effusion Lymphoma In primary effusion lymphoma, a herpesvirus 8 (HHV-8)–associated neoplasm that is most common in HIV-coinfected patients, cells often express CD38.
Nirav N Shah, Arun K Singavi, Alexandra Harrington +2 more
exaly +2 more sources

Plasmablastic Lymphoma and Primary Effusion Lymphoma

2019
Plasmablastic lymphoma (PBL) and primary effusion lymphoma (PEL) are rare CD20-negative variants of diffuse large B-cell lymphoma. Both conditions were initially described in patients with underlying HIV infection, but cases of PBL and PEL have been more recently diagnosed in other immunocompromised states and in immunocompetent individuals.
Thomas A. Guerrero-Garcia, Jorge J. Castillo +1 more
openaire +1 more source

Pleural effusion as the presentation for primary effusion lymphoma